The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Rhodes Jason P | Director | Sell(S) | 322K | $25.00 | $8.1M |
| Aug 14, 2026 | Rhodes Jason P | Director | Sell(S) | 478K | $25.00 | $12.0M |
| Aug 14, 2026 | Rhodes Jason P | Director | Sell(S) | 1.4M | $25.00 | $34.0M |
| Aug 13, 2026 | Rhodes Jason P | Director | Sell(S) | 64K | $26.20 | $1.7M |
| Aug 13, 2026 | Rhodes Jason P | Director | Sell(S) | 94K | $26.20 | $2.5M |
| Aug 13, 2026 | Rhodes Jason P | Director | Sell(S) | 268K | $26.20 | $7.0M |
| Aug 13, 2026 | Lucera Erick | Chief Financial Officer | Sell(S) | 2K | $26.28 | $47K |
| Aug 13, 2026 | Cox John | CEO & President, Director | Sell(S) | 5K | $26.28 | $131K |
| Aug 13, 2026 | Kerr Douglas | Chief Medical Officer | Sell(S) | 2K | $26.28 | $41K |
| Aug 13, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell(S) | 226 | $26.28 | $6K |
| Jul 27, 2026 | Kersten Dirk | Director | Sell(S) | 256K | $25.50 | $6.5M |
| Jul 27, 2026 | Kersten Dirk | Director | Sell(S) | 5K | $26.04 | $140K |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 124K | $23.17 | $2.9M |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 30K | $23.62 | $699K |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 63K | $23.17 | $1.4M |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 15K | $23.62 | $351K |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 49K | $23.17 | $1.1M |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 12K | $23.62 | $276K |
| Jul 7, 2026 | Rhodes Jason P | Director | Sell(S) | 5K | $23.61 | $118K |
| Jul 6, 2026 | Rhodes Jason P | Director | Sell(S) | 253K | $22.79 | $5.8M |
| Jul 6, 2026 | Rhodes Jason P | Director | Sell(S) | 127K | $22.79 | $2.9M |
| Jul 6, 2026 | Rhodes Jason P | Director | Sell(S) | 100K | $22.79 | $2.3M |
| Jun 29, 2026 | Rhodes Jason P | Director | Sell(S) | 103K | $21.14 | $2.2M |
| Jun 29, 2026 | Rhodes Jason P | Director | Sell(S) | 52K | $21.14 | $1.1M |
| Jun 29, 2026 | Rhodes Jason P | Director | Sell(S) | 41K | $21.14 | $860K |
| Jun 26, 2026 | Rhodes Jason P | Director | Sell(S) | 163K | $21.28 | $3.5M |
| Jun 26, 2026 | Rhodes Jason P | Director | Sell(S) | 82K | $21.28 | $1.7M |
| Jun 26, 2026 | Rhodes Jason P | Director | Sell(S) | 64K | $21.28 | $1.4M |
| Jun 25, 2026 | Lucera Erick | Chief Financial Officer | Sell(S) | 2K | $20.37 | $48K |
| Jun 25, 2026 | Rhodes Jason P | Director | Sell(S) | 13K | $21.10 | $268K |
| Jun 25, 2026 | Rhodes Jason P | Director | Sell(S) | 6K | $21.10 | $135K |
| Jun 25, 2026 | Rhodes Jason P | Director | Sell(S) | 5K | $21.10 | $106K |
| Jun 24, 2026 | Rhodes Jason P | Director | Sell(S) | 51K | $21.02 | $1.1M |
| Jun 24, 2026 | Rhodes Jason P | Director | Sell(S) | 25K | $21.02 | $534K |
| Jun 24, 2026 | Rhodes Jason P | Director | Sell(S) | 20K | $21.02 | $420K |
| Jun 23, 2026 | Kersten Dirk | Director | Sell(S) | 72K | $21.04 | $1.5M |
| Jun 23, 2026 | Kersten Dirk | Director | Sell(S) | 2K | $21.47 | $36K |
| Jun 23, 2026 | Rhodes Jason P | Director | Sell(S) | 78K | $21.13 | $1.6M |
| Jun 23, 2026 | Rhodes Jason P | Director | Sell(S) | 39K | $21.13 | $827K |
| Jun 23, 2026 | Rhodes Jason P | Director | Sell(S) | 31K | $21.13 | $650K |
| Jun 22, 2026 | Greene Barry E | Director | Grant(A) | 57K | — | $0 |
| Jun 22, 2026 | Kersten Dirk | Director | Sell(S) | 191K | $20.57 | $3.9M |
| Jun 18, 2026 | Kersten Dirk | Director | Sell(S) | 47K | $20.07 | $941K |
| Jun 17, 2026 | Kersten Dirk | Director | Sell(S) | 37K | $20.14 | $754K |
| Jun 16, 2026 | Kerr Douglas | Chief Medical Officer | Sell(S) | 887 | $18.33 | $16K |
| Jun 16, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell(S) | 145 | $18.33 | $3K |
| Jun 16, 2026 | Cox John | CEO & President, Director | Sell(S) | 3K | $18.33 | $49K |
| Jun 8, 2026 | Posner Brian S | Director | Buy(P) | 2K | $16.94 | $34K |
| Jun 5, 2026 | Stehman-Breen Catherine | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Posner Brian S | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Rhodes Jason P | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Hurwitz Edward | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Lubner David Charles | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Kersten Dirk | Director | Grant(A) | 35K | — | $0 |
| Jun 5, 2026 | Incerti Carlo | Director | Grant(A) | 35K | — | $0 |
| Jun 3, 2026 | Posner Brian S | Director | Buy(P) | 3K | $17.48 | $44K |
| May 26, 2026 | Posner Brian S | Director | Buy(P) | 2K | $18.21 | $36K |
| May 20, 2026 | Posner Brian S | Director | Buy(P) | 3K | $17.12 | $43K |
| May 13, 2026 | Cox John | CEO & President, Director | Sell(S) | 3K | $18.36 | $61K |
| May 13, 2026 | Lucera Erick | Chief Financial Officer | Sell(S) | 1K | $18.36 | $27K |
| May 13, 2026 | Kerr Douglas | Chief Medical Officer | Sell(S) | 2K | $18.36 | $29K |
| May 13, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell(S) | 228 | $18.36 | $4K |
| May 6, 2026 | Rhodes Jason P | Director | Sell(S) | 22K | $18.18 | $399K |
| May 6, 2026 | Rhodes Jason P | Director | Sell(S) | 44K | $18.18 | $793K |
| May 6, 2026 | Rhodes Jason P | Director | Sell(S) | 428 | $18.18 | $8K |
| May 6, 2026 | Rhodes Jason P | Director | Sell(S) | 17K | $18.18 | $313K |
| May 5, 2026 | Rhodes Jason P | Director | Sell(S) | 3K | $18.03 | $55K |
| May 5, 2026 | Rhodes Jason P | Director | Sell(S) | 6K | $18.03 | $110K |
| May 5, 2026 | Rhodes Jason P | Director | Sell(S) | 60 | $18.03 | $1K |
| May 5, 2026 | Rhodes Jason P | Director | Sell(S) | 2K | $18.03 | $43K |
| May 4, 2026 | Rhodes Jason P | Director | Sell(S) | 3K | $18.00 | $56K |
| May 4, 2026 | Rhodes Jason P | Director | Sell(S) | 6K | $18.00 | $112K |
| May 4, 2026 | Rhodes Jason P | Director | Sell(S) | 61 | $18.00 | $1K |
| May 4, 2026 | Rhodes Jason P | Director | Sell(S) | 2K | $18.00 | $44K |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 60K | $18.38 | $1.1M |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 119K | $18.38 | $2.2M |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 1K | $18.38 | $22K |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 47K | $18.38 | $865K |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 26 | $19.00 | $494 |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 52 | $19.00 | $988 |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 1 | $19.00 | $19 |
| Apr 28, 2026 | Rhodes Jason P | Director | Sell(S) | 21 | $19.00 | $399 |
| Apr 27, 2026 | Rhodes Jason P | Director | Sell(S) | 46K | $18.15 | $830K |
| Apr 27, 2026 | Rhodes Jason P | Director | Sell(S) | 91K | $18.15 | $1.7M |
| Apr 27, 2026 | Rhodes Jason P | Director | Sell(S) | 894 | $18.15 | $16K |
| Apr 27, 2026 | Rhodes Jason P | Director | Sell(S) | 36K | $18.15 | $652K |
| Apr 24, 2026 | Rhodes Jason P | Director | Sell(S) | 36K | $18.48 | $672K |
| Apr 24, 2026 | Rhodes Jason P | Director | Sell(S) | 72K | $18.48 | $1.3M |
| Apr 24, 2026 | Rhodes Jason P | Director | Sell(S) | 710 | $18.48 | $13K |
| Apr 24, 2026 | Rhodes Jason P | Director | Sell(S) | 29K | $18.48 | $528K |
| Apr 24, 2026 | Lubner David Charles | Director | Gift(G) | 54K | — | $0 |
| Apr 23, 2026 | Rhodes Jason P | Director | Sell(S) | 19K | $19.19 | $370K |
| Apr 23, 2026 | Rhodes Jason P | Director | Sell(S) | 38K | $19.19 | $735K |
| Apr 23, 2026 | Rhodes Jason P | Director | Sell(S) | 377 | $19.19 | $7K |
| Apr 23, 2026 | Rhodes Jason P | Director | Sell(S) | 15K | $19.19 | $291K |
| Apr 22, 2026 | Rhodes Jason P | Director | Sell(S) | 76K | $19.68 | $1.5M |
| Apr 22, 2026 | Rhodes Jason P | Director | Sell(S) | 151K | $19.68 | $3.0M |
| Apr 22, 2026 | Rhodes Jason P | Director | Sell(S) | 1K | $19.68 | $29K |
| Apr 22, 2026 | Rhodes Jason P | Director | Sell(S) | 60K | $19.68 | $1.2M |
| Apr 22, 2026 | Kersten Dirk | Director | Sell(S) | 3K | $20.00 | $53K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for DYN